Multiple Classified Advertising Items Literature Hampton Races Ennis Chronicle: Kent Reform Dinner Revolution in Brazil Election of Prince Leopold to ...
1831 - Gale Group | Sunday Times HA GDA
Hans‐Jörg Althaus, Peter Haan, Roland W. Scholz,
... LCA guide method, Swiss EPA method, and Swiss FEDRO method) in detail. The additional basis for the ... maximum noise levels of single vehicles. The Swiss FEDRO method is based on an inappropriate assumption since ... the Danish LCA guide method and the Swiss FEDRO method are not suitable for our purpose, the ... in the Swiss EPA and in the Swiss FEDRO methods.
Tópico(s): Acoustic Wave Phenomena Research
2009 - Springer Science+Business Media | The International Journal of Life Cycle Assessment
Walter Kaufmann, Manuel Álvarez,
... the Guidelines of the Swiss Federal Roads Office (FEDRO), edition 1990, established as a general rule that ... than 40% of the existing bridges on the FEDRO network are (semi-)integral structures, a considerable amount ... this aim, in the current revision of the FEDRO Guidelines, the design provisions for integral bridges have ...
Tópico(s): Structural Behavior of Reinforced Concrete
2011 - Taylor & Francis | Structural Engineering International
Francesco Bertolini, Alberto Agazzi, Fedro A. Peccatori, Giovanni Martinelli, Maria Teresa Sandri,
... for more papers by this authorFedro Peccatori MD, Fedro Peccatori MD Hematology-Oncology UnitSearch for more papers ... for more papers by this authorFedro Peccatori MD, Fedro Peccatori MD Hematology-Oncology UnitSearch for more papers ...
Tópico(s): Blood groups and transfusion
2000 - Wiley | Transfusion
Abstract Il brano del Fedro (269e1-270c5) in cui è menzionato Ippocrate e il suo metodo è uno dei più controversi dell'opera platonica. Alcuni ...
Tópico(s): Classical Antiquity Studies
2001 - Brill | Phronesis
Ann Partridge, Olivia Pagani, Samuel M. Niman, Monica Ruggeri, Fedro A. Peccatori, Hatem A. Azim, Marco Colleoni, Cristina Saura, Chikako Shimizu, Anna Barbro Sætersdal, Judith R. Kroep, Audrey Mailliez, Ellen Warner, Virginia F. Borges, Frédéric Amant, Andrea Gombos, Akemi Kataoka, Christine Rousset‐Jablonski, Simona Borštnar, Junko Takei, Jeong Eon Lee, Janice M. Walshe, Manuel Ruíz Borrego, Halle C. F. Moore, Christobel Saunders, Vesna Bjelic‐Radisic, Sneẑana Šušnjar, Fátima Cardoso, Karen L. Smith, Teresa Ferreiro Vilarino, Karin Ribi, Kathryn Ruddy, Sarra El-Abed, Martine Piccart, Larissa A. Korde, Aron Goldhirsch, Richard D. Gelber,
... Partridge, Olivia Pagani, Samuel M. Niman, Monica Ruggeri, Fedro Alessandro A. Peccatori, Hatem A. Azim, Marco Colleoni, ...
Tópico(s): Cancer Risks and Factors
2023 - American Association for Cancer Research | Cancer Research
... un análisis comparado de los tres discursos del Fedro de Platón. El objetivo es mostrar que, pese ...
Tópico(s): Foucault, Power, and Ethics
2015 - University of Santiago de Compostela | Agora papeles de Filosofía
Ann H. Partridge, Samuel M. Niman, Monica Ruggeri, Fedro A. Peccatori, Hatem A. Azim, Marco Colleoni, Cristina Saura, Chikako Shimizu, Anna Barbro Sætersdal, Judith R. Kroep, Audrey Mailliez, Ellen Warner, Virginia F. Borges, Frédéric Amant, Andrea Gombos, Akemi Kataoka, Christine Rousset‐Jablonski, Simona Borštnar, Junko Takei, Jeong Eun Lee, Janice M. Walshe, Manuel Ruíz‐Borrego, Halle C. F. Moore, Christobel Saunders, Vesna Bjelic‐Radisic, Sneẑana Šušnjar, Fátima Cardoso, Karen L. Smith, Teresa I. Ferreiro, Karin Ribi, Kathryn J. Ruddy, Roswitha Kammler, Sarra El-Abed, Giuseppe Viale, Martine Piccart, Larissa A. Korde, Aron Goldhirsch, Richard D. Gelber, Olivia Pagani,
Prospective data on the risk of recurrence among women with hormone receptor–positive early breast cancer who temporarily discontinue endocrine therapy to attempt pregnancy are lacking. Download a PDF of the Research Summary. We conducted a single-group trial in which we evaluated the temporary interruption of adjuvant endocrine therapy to attempt pregnancy in young women with previous breast cancer. Eligible women were 42 years of age or younger; had had stage I, II, or III disease; had received ...
Tópico(s): Childhood Cancer Survivors' Quality of Life
2023 - Massachusetts Medical Society | New England Journal of Medicine
Matteo Lambertini, Marcello Ceppi, Richard A. Anderson, David Cameron, M. Bruzzone, Maria Alice Franzoi, Claudia Massarotti, Sarra El-Abed, Yingbo Wang, Christophe Lecocq, Paolo Nucíforo, Rebecca Rolyance, Lajos Pusztai, Joohyuk Sohn, Maria Maddalena Latocca, Luca Arecco, Barbara Pistilli, Kathryn J. Ruddy, Alberto Ballestrero, Lucia Del Mastro, Fedro A. Peccatori, Ann H. Partridge, Cristina Saura, Michael Untch, Martine Piccart, Serena Di Cosimo, Evandro de Azambuja, Isabelle Demeestere,
Background: The potential gonadotoxicity of anti-HER2 agents remains largely unknown, and limited, conflicting evidence exists for taxanes. Antimüllerian hormone (AMH) is an established biomarker of ovarian reserve that may aid in quantifying anticancer treatment–induced gonadotoxicity. Patients and Methods: The present biomarker analysis of the randomized phase III neoadjuvant NeoALTTO trial included premenopausal women aged ≤45 years at diagnosis of HER2-positive early breast cancer with available ...
Tópico(s): Breast Cancer Treatment Studies
2023 - National Comprehensive Cancer | Journal of the National Comprehensive Cancer Network
Annalisa Trama, Dan Stark, Ivana Božović‐Spasojević, Nathalie Gaspar, Fedro A. Peccatori, Angela Toss, Alice Bernasconi, Paola Quarello, Katrin Scheinemann, S. Jezdic, Anne Blondeel, Giannis Mountzios, Stefan Bielack, Emmanouil Saloustros, Andrea Ferrari,
•Cancers in AYAs are rare.•Cancers in AYAs are increasing in the current era.•Breast, cervical and thyroid cancers account for a substantial burden of cancer among AYAs, especially among young women.•Differences in AYA cancer incidence and mortality exist within European countries.•Eastern European countries are lagging behind in survival of many cancer types in AYAs. BackgroundCancer epidemiology is unique in adolescents and young adults (AYAs; aged 15-39 years). The European Society for Medical ...
Tópico(s): Acute Lymphoblastic Leukemia research
2023 - Elsevier BV | ESMO Open
David Cibula, Maria Rosaria Raspollini, François Planchamp, Carlos Centeno, Cyrus Chargari, Ana Félix, D. Fischerová, Daniela Jahnn-Kuch, Florence Joly, Christhardt Köhler, Sigurd Lax, Domenica Lorusso, Umesh Mahantshetty, Patrice Mathevet, Raj Naik, Remi A. Nout, Ana Oaknin, Fedro A. Peccatori, Jan Persson, Denis Querleu, Sandra Rubio Bernabé, Maximilian Schmid, Artem Stepanyan, Valentyn Svintsitskyi, Karl Tamussino, Ignacio Zapardiel, Jacob Christian Lindegaard,
In 2018, the European Society of Gynecological Oncology (ESGO) jointly with the European Society for Radiotherapy and Oncology (ESTRO) and the European Society of Pathology (ESP) published evidence-based guidelines for the management of patients with cervical cancer. Given the large body of new evidence addressing the management of cervical cancer, the three sister societies jointly decided to update these evidence-based guidelines. The update includes new topics to provide comprehensive guidelines ...
Tópico(s): Cancer Risks and Factors
2023 - Springer Science+Business Media | Virchows Archiv
Sibylle Loibl, Hatem A. Azim, Thomas Bachelot, Paul Berveiller, Ana Bosch, Elyce Cardonick, Carsten Denkert, M Halaška, Maria Hoeltzenbein, Anna L.V. Johansson, Charlotte Maggen, Udo R. Markert, Fedro A. Peccatori, Philip Poortmans, Emmanouil Saloustros, Cristina Saura, Peter Schmid, Emmanouil Stamatakis, Marry van den Heuvel‐Eibrink, Mathilde van Gerwen, Vincent Vandecaveye, George Pentheroudakis, Giuseppe Curigliano, Frédéric Amant,
The management of breast cancer during pregnancy (PrBC) is a relatively rare indication and an area where no or little evidence is available since randomized controlled trials cannot be conducted. In general, advances related to breast cancer (BC) treatment outside pregnancy cannot always be translated to PrBC, because both the interests of the mother and of the unborn should be considered. Evidence remains limited and/or conflicting in some specific areas where the optimal approach remains controversial. ...
Tópico(s): Global Cancer Incidence and Screening
2023 - Elsevier BV | Annals of Oncology
David Cibula, Maria Rosaria Raspollini, François Planchamp, Carlos Centeno, Cyrus Chargari, Ana Félix, D. Fischerová, Daniela Jahnn-Kuch, Florence Joly, Christhardt Köhler, Sigurd Lax, Domenica Lorusso, Umesh Mahantshetty, Patrice Mathevet, Mr Raj Naik, Remi A. Nout, Ana Oaknin, Fedro A. Peccatori, Jan Persson, Denis Querleu, Sandra Rubio Bernabé, Maximilian Schmid, Artem Stepanyan, Valentyn Svintsitskyi, Karl Tamussino, Ignacio Zapardiel, Jacob Christian Lindegaard,
In 2018, the European Society of Gynecological Oncology (ESGO) jointly with the European Society for Radiotherapy and Oncology (ESTRO) and the European Society of Pathology (ESP) published evidence-based guidelines for the management of patients with cervical cancer. Given the large body of new evidence addressing the management of cervical cancer, the three sister societies jointly decided to update these evidence-based guidelines. The update includes new topics to provide comprehensive guidelines ...
Tópico(s): Cancer Risks and Factors
2023 - Elsevier BV | Radiotherapy and Oncology
Produção Nacional
Revisado por pares
Matteo Lambertini, Eva Blondeaux, Elisa Agostinetto, Anne-Sophie Hamy, Hee Jeong Kim, Antonio Di Meglio, Rinat Bernstein‐Molho, Florentine Hilbers, Katarzyna Pogoda, Estela Carrasco, Kevin Punie, Jyoti Bajpai, Michail Ignatiadis, Halle C. F. Moore, Kelly‐Anne Phillips, Angela Toss, Christine Rousset‐Jablonski, Fedro A. Peccatori, Tiphaine Renaud, Alberta Ferrari, Shani Paluch–Shimon, Robert Fruscio, Wanda Cui, Stephanie M. Wong, Claudio Vernieri, Kathryn J. Ruddy, Maria Vittoria Dieci, Alexios Matikas, Mariya Rozenblit, Cynthia Villarreal‐Garza, Laura De Marchis, Lucia Del Mastro, Fabio Puglisi, Maria Del Pilar Estevez Diz, Kenny A. Rodriguez‐Wallberg, Bela Mriňáková, Sarah Meister, Luca Livraghi, Florian Clatot, Rinat Yerushalmi, Carmine De Angelis, Rodrigo Sánchez-Bayona, Icro Meattini, Natalia Cichowska-Cwalińska, Martine Berlière, Mahmoud Salama, Ugo De Giorgi, Amir Sonnenblick, Camila Chiodi, Young‐Jin Lee, Camille Maria, Hatem A. Azim, Luca Boni, Ann H. Partridge, Evandro de Azambuja, Chiara Molinelli, Marianne Paesmans, Lieveke Ameye, Frédéric Amant, Hilde Brems, Sileny Han, Sigrid Hatse, Ines Nevelsteen, Patrick Neven, Ann Smeets, Chantal Van Rompuy, Hans Wildiers, François Duhoux, Federica Giugliano, Carmen Criscitiello, Roberto Borea, Luca Arecco, Alessandra Chirco, Federica Bini, Marta Venturelli, Laura Cortesi, Riccardo Ponzone, Nicoletta Tomasi Cont, Judith Balmañà, Rossella Graffeo, Helena Luna Pais, Alejandro Mohar, Tamara Palacios, Lucia Da Ros, Gianmaria Miolo, Mattia Garutti, Brenno Pastò, Simon Spazzapan, Alessandra Viel, José Alejandro Pérez Fidalgo, Renata Colombo Bonadio, Tamar Peretz‐Yablonski, Chiara Annunziata Pasqualina Anghelone, Angelica Della Valle, Maria Campanella, Valentina Guarneri, Raphaëlle Bas, Pierre-Étienne Heudel, Olivier Trédan, Solenne de Talouet, Valérie Bonadona, Christine Lasset, Marion Acheritogaray, Claire Sénéchal, Monica Mariño, Octavi Córdoba, Didi Feldman, Romina Pesce, Carol Allemand, Cecilia Riggi, Maria Belen Iriarte, Alfonso Cortés Salgado, Javier Cortés, María Gión, Cristina Saavedra, A. Rodríguez, Bárbara Adamo, Aleix Prat, Anna Hester, Sofia Dunckelmann, Nadia Harbeck, Maximilian Marhold, Rupert Bartsch, Constantin Mannsbarth, Lazar Popović, Ivana Božović‐Spasojević, Ana Krivokuća, Marija Dimitrijević, Luca Visani, Beatrice Bettazzi, Lorenzo Livi, Caterina Sposetti, Valentina Sini, Alessia Rognone, Giampaolo Bianchini, Maria Grazia Patricelli, Emanuela Rabaiotti, Oreste Gentilini, Andrea Fontana, Giulia Acconci, Erica Baldacci, Giulia Bianchini, Mirco Pistelli, Sabine C. Linn, Sieta Kleiterp, Daoud Ait Moha, Rajiv Sarin, Anberson Sekar, Francesco Atzori, Francesco Loi, Mariele Dessì, Sarah O’Connor, Stephanie Nesci, Paul A. James, Chris Michael, Fergus J. Couch, Janet E. Olson, Nicole L. Larson, Siddhartha Yadav, Nerea Lopetegui, Lisa A. Carey, Yara Abdou, Paola Zagami, Roberta Di Rocco, Margherita Baldassarri, Carmelo Bengala, Elene Mariamidze, Stephanie L. Graff, Stephanie Haddad, Emma Safran, Leonor Vasconcelos de Matos, Arlindo R. Ferreira, Serena Negri, Cristina Dell'Oro, Alessandra Inzoli, Clarissa Costa, Liliana Marchetta, Maryam B. Lustberg, Deanna Blansky, June Jeon, Norin Ansari, Dione Aguilar-y-Méndez, Teresa K. Woodruff, Monique Swain, Madison Miller, Richard E. Leach, Alessandra Fabi, Antonella Palazzo, Ida Paris, Joanna Kufel-Grabowska, Agnieszka Synowiec, M. Hancinova, L. Tarbaj, Emir Sokolović, S. Beslija, Timur Cerić, Berisa Hasanbegović, William D. Foulkes, Manuel A. Bianchi, Pablo Tolosa, Laura Alvaro, Louise Eriksson Bergman, Nicoleta Antone, Cristina Damian,
Importance Young women with breast cancer who have germline pathogenic variants in BRCA1 or BRCA2 face unique challenges regarding fertility. Previous studies demonstrating the feasibility and safety of pregnancy in breast cancer survivors included limited data regarding BRCA carriers. Objective To investigate cumulative incidence of pregnancy and disease-free survival in young women who are BRCA carriers. Design, Setting, and Participants International, multicenter, hospital-based, retrospective ...
Tópico(s): BRCA gene mutations in cancer
2023 - American Medical Association | JAMA
David Cibula, Maria Rosaria Raspollini, François Planchamp, Carlos Centeno, Cyrus Chargari, Ana Félix, D. Fischerová, Daniela Jahnn-Kuch, Florence Joly, Christhardt Köhler, Sigurd Lax, Domenica Lorusso, Umesh Mahantshetty, Patrice Mathevet, Raj Naik, Remi A. Nout, Ana Oaknin, Fedro A. Peccatori, Jan Persson, Denis Querleu, Sandra Rubio Bernabé, Maximilian Schmid, Artem Stepanyan, Valentyn Svintsitskyi, Karl Tamussino, Ignacio Zapardiel, Jacob Christian Lindegaard,
In 2018, the European Society of Gynecological Oncology (ESGO) jointly with the European Society for Radiotherapy and Oncology (ESTRO) and the European Society of Pathology (ESP) published evidence-based guidelines for the management of patients with cervical cancer. Given the large body of new evidence addressing the management of cervical cancer, the three sister societies jointly decided to update these evidence-based guidelines. The update includes new topics to provide comprehensive guidelines ...
Tópico(s): Cancer Risks and Factors
2023 - BMJ | International Journal of Gynecological Cancer
Elham Sajjadi, Konstantinos Venetis, Marianna Noale, Hatem A. Azim, Concetta Blundo, Giuseppina Bonizzi, Eugenia Di Loreto, Giovanna Scarfone, Stefano Ferrero, Stefania Maggi, Massimo Barberis, Paolo Veronesi, Viviana Galimberti, Giuseppe Viale, Nicola Fusco, Fedro A. Peccatori, Elena Guerini‐Rocco,
Breast cancer during pregnancy (PrBC) is a rare tumor with only a little information on its immune landscape. Here, we sought to characterize the cellular composition of the tumor microenvironment (TME) of PrBC and identify its differences from early-onset breast cancer (EOBC) in non-pregnant women. A total of 83 PrBC and 89 EOBC were selected from our Institutional registry and subjected to tumor-infiltrating lymphocytes (TILs) profiling and immunohistochemistry for CD4, CD8, forkhead box P3 (FOXP3), ...
Tópico(s): Cancer Immunotherapy and Biomarkers
2022 - Multidisciplinary Digital Publishing Institute | Cells
Richard A. Anderson, David Cameron, Florian Clatot, Isabelle Demeestere, Matteo Lambertini, Scott M. Nelson, Fedro A. Peccatori,
Female patients undergoing anticancer treatment are at elevated risk of adverse ovarian outcomes including infertility and premature ovarian insufficiency (POI), which is associated with short- and long-term health risks. Anti-Müllerian hormone (AMH) is a key biomarker of ovarian reserve, but its role prior to and after cancer treatment is less well understood.To conduct a systematic review evaluating AMH as a biomarker of ovarian reserve and POI before and after anticancer treatment, which has become ...
Tópico(s): Reproductive Biology and Fertility
2022 - Oxford University Press | Human Reproduction Update
Shani Paluch–Shimon, Fátima Cardoso, Ann H. Partridge, Omalkhair Abulkhair, Hatem A. Azim, G. Bianchi-Micheli, Maria João Cardoso, Giuseppe Curigliano, Karen A. Gelmon, Oreste Gentilini, Nadia Harbeck, Bella Kaufman, S.B. Kim, Q. Liu, J. Merschdorf, Philip Poortmans, Giancarlo Pruneri, Elżbieta Senkus, Bhawna Sirohi, Tanja Španić, Virpi Sulosaari, Fedro A. Peccatori, Olivia Pagani,
•Breast cancer in young women encompasses unique treatment and survivorship considerations.•Fertility, ovarian function suppression and premature menopause are major issues that need to be addressed.•The presence of a germline pathogenic variant impacts risk reduction measures, local management and systemic therapy.•Research on how new systemic therapies impact fertility and ovarian function is urgently needed. We dedicate this manuscript in memory of a dear friend and colleague Bella Kaufman.The ...
Tópico(s): Breast Cancer Treatment Studies
2022 - Elsevier BV | Annals of Oncology
Frédéric Amant, Hanne Lefrère, Virginia F. Borges, Elyce Cardonick, Matteo Lambertini, Sibylle Loibl, Fedro A. Peccatori, Ann H. Partridge, Pepper Schedin,
The definition of pregnancy-associated breast cancer (PABC) is inconsistently given as either breast cancer diagnosed exclusively during pregnancy, or combined with cases diagnosed within 6 months to 1 year after the birth. 1 Lyons T Schedin P Borges V Pregnancy and breast cancer: when they collide. J Mammary Gland Biol Neoplasia. 2009; 14: 87-98 Google Scholar Although pregnancy and the postpartum period are intertwined, evolving evidence supports considering breast cancer that occurs during pregnancy ( ...
Tópico(s): Global Cancer Incidence and Screening
2021 - Elsevier BV | The Lancet Oncology
Andrea Ferrari, Dan Stark, Fedro A. Peccatori, Lorna A. Fern, Valérie Laurence, Nathalie Gaspar, Ivana Božović‐Spasojević, Owen P. Smith, Johan De Munter, Katarzyna Derwich, Lars Hjorth, Winette T.A. van der Graaf, Louise Soanes, S. Jezdic, Anne Blondeel, Stefan Bielack, Jean-Yves Douillard, Giannis Mountzios, Emmanouil Saloustros,
•Reflects the ESMO/SIOPE AYA Working Group position regarding current AYA cancer care, challenges and possible solutions.•Key challenges are lack of understanding of AYA cancer biology, access to specialised centres, available clinical trials.•Key recommendations include diversifying interprofessional cooperation in AYA cancer care and measures to improve trial accrual.•This defines a common vision that can lead to improved outcomes for AYA with cancer in Europe. It is well recognised that adolescents ...
Tópico(s): Adolescent and Pediatric Healthcare
2021 - Elsevier BV | ESMO Open
Matteo Lambertini, Eva Blondeaux, M. Bruzzone, Marta Perachino, Richard A. Anderson, Evandro de Azambuja, Philip D. Poorvu, Hee Jeong Kim, Cynthia Villarreal‐Garza, Barbara Pistilli, Inês Vaz-Luís, Cristina Saura, Kathryn J. Ruddy, Maria Alice Franzoi, Chiara Sertoli, Marcello Ceppi, Hatem A. Azim, Frédéric Amant, Isabelle Demeestere, Lucia Del Mastro, Ann H. Partridge, Olivia Pagani, Fedro A. Peccatori,
Many patients and physicians remain concerned about the potential detrimental effects of pregnancy after breast cancer (BC) in terms of reproductive outcomes and maternal safety. This systematic review and meta-analysis aimed at providing updated evidence on these topics.A systematic literature review was conducted to identify studies including patients with a pregnancy after BC (PROSPERO number CRD42020158324). Likelihood of pregnancy after BC, their reproductive outcomes, and maternal safety were ...
Tópico(s): Childhood Cancer Survivors' Quality of Life
2021 - Lippincott Williams & Wilkins | Journal of Clinical Oncology
Ann H. Partridge, Samuel M. Niman, Monica Ruggeri, Fedro A. Peccatori, Hatem A. Azim, Marco Colleoni, Cristina Saura, Chikako Shimizu, Anna Barbro Sætersdal, Judith R. Kroep, Audrey Mailliez, Ellen Warner, Virginia F. Borges, Frédéric Amant, Andrea Gombos, Akemi Kataoka, Christine Rousset‐Jablonski, Simona Borštnar, Junko Takei, Joon Jeong, Janice M. Walshe, Manuel Ruíz Borrego, Halle C. F. Moore, Christobel Saunders, Fátima Cardoso, Sneẑana Šušnjar, Vesna Bjelic‐Radisic, Karen L. Smith, Martine Piccart, Larissa A. Korde, Aron Goldhirsch, Richard D. Gelber, Olivia Pagani,
Premenopausal women with early hormone-receptor positive (HR+) breast cancer receive 5-10 years of adjuvant endocrine therapy (ET) during which pregnancy is contraindicated and fertility may wane. The POSITIVE study investigates the impact of temporary ET interruption to allow pregnancy.POSITIVE enrolled women with stage I-III HR + early breast cancer, ≤42 years, who had received 18-30 months of adjuvant ET and wished to interrupt ET for pregnancy. Treatment interruption for up to 2 years was permitted ...
Tópico(s): Reproductive Biology and Fertility
2021 - Elsevier BV | The Breast
Produção Nacional
Revisado por pares
Teresa K. Woodruff, Lauren Ataman, Kelly S. Acharya, Teresa Almeida‐Santos, Antoinette Anazodo, Richard A. Anderson, Leslie Appiah, Joy Bader, Kerri Becktell, Robert E. Brannigan, Lesley Breech, María T. Bourlon, Žana Bumbulienė, Karen Burns, Lisa Campo‐Engelstein, Jacira Ribeiro Campos, Grace M. Centola, Maurício B. Chehin, Diane Chen, Michel De Vos, Francesca E. Duncan, Ahmed El‐Damen, Douglas Fair, Yemi Famuyiwa, Patricia Y. Fechner, Paula Fontoura, Olivia Frias, Sabrina A. Gerkowicz, Jill P. Ginsberg, Clarisa R. Gracia, Kara N. Goldman, Veronica Gomez‐Lobo, Brent Hazelrigg, Michael H. Hsieh, Luis R. Hoyos, Alfonso Hoyos-Martínez, Robert Jach, Jacek Jassem, Murid Javed, Yasmin Jayasinghe, Roohi Jeelani, Jacqueline S. Jeruss, Nalini Kaul-Mahajan, Jessica Keim‐Malpass, Tyler G. Ketterl, Mohamed Khrouf, Dana Kimelman, Atsuko Kusuhara, William H. Kutteh, Monica M. Laronda, Jung Ryeol Lee, Vicky Lehmann, Joseph M. Letourneau, Lynda K. McGinnis, Eileen M. McMahon, Lillian R. Meacham, Monserrat Fabiola Velez Mijangos, Molly B. Moravek, Leena Nahata, George Moses Ogweno, Kyle E. Orwig, Mary Ellen Pavone, Fedro A. Peccatori, Romina Pesce, Hanna Pulaski, Gwendolyn P. Quinn, R. Quintana, Tomas Quintana, Bruno Ramalho de Carvalho, Rosalind Ramsey‐Goldman, Joyce Reinecke, Fernando M. Reis, Julie Sroga Rios, Alice Rhoton-Vlasak, Kenny A. Rodriguez‐Wallberg, Cassandra Roeca, Seth J. Rotz, Erin E. Rowell, Mahmoud Salama, Amanda Saraf, Aníbal Scarella, Tara Schafer-Kalkhoff, Deb Schmidt, Suneeta Senapati, Divya Shah, Ariella Shikanov, Margarett Shnorhavorian, Jodi Skiles, James F. Smith, Kristin Smith, Fabio Sobral, Kyle Stimpert, H. Irene Su, Kouhei Sugimoto, Nao Suzuki, Mili Thakur, David Victorson, Luz Viale, Wendy Vitek, William H. Wallace, Ellen Wartella, Lynn M. Westphal, Stacy Whiteside, Lea H. Wilcox, Christine Wyns, Shuo Xiao, Jing Xu, Mary B. Zelinski,
Today, male and female adult and pediatric cancer patients, individuals transitioning between gender identities, and other individuals facing health extending but fertility limiting treatments can look forward to a fertile future. This is, in part, due to the work of members associated with the Oncofertility Consortium. The Oncofertility Consortium is an international, interdisciplinary initiative originally designed to explore the urgent unmet need associated with the reproductive future of cancer ...
Tópico(s): Renal and related cancers
2021 - Springer Science+Business Media | Journal of Assisted Reproduction and Genetics
Mathilde van Gerwen, Charlotte Maggen, Elyce Cardonick, Emma J. Verwaaijen, Marry van den Heuvel‐Eibrink, R.G. Shmakov, Ingrid Boere, Mina Mhallem Gzirí, Petronella B. Ottevanger, Christianne Lok, M Halaška, Long Ting Shao, Ilana Struys, Elisabeth M. van Dijk‐Lokkart, Kristel Van Calsteren, Robert Fruscio, Paolo Zola, Giovanna Scarfone, Frédéric Amant, Anthony Richards, Stephan Polterauer, Andrei Pletnev, Sevilay Altıntaş, Sileny Han, Magali Verheecke, Philippe Tummers, Tessa van Oostveldt, Vincent Rigo, Eduardo Paulino, Jaroslav Klát, David Cibula, Kasper Ingerslev, Lone Storgaard, Berit Woetmann Pedersen, Cristel Maria Sørensen-Hjortshøj, Mona Aarenstrup Karlsen, Paul Berveiller, Dominik Denschlag, Dimitrios Haidopoulos, Georgios‐Marios Makris, Ioannis Kalogiannidis, Zoltán Novàk, Lorenzo Ceppi, Monica Fumagalli, Giorgia Mangili, Fedro A. Peccatori, Bianca Masturzo, Anna Fagotti, Matteo Lambertini, Felice Petraglia, Davia Vaitkiene, Adrius Gaurilcikas, Alvaro Cabrera Garcia, Line Bjørge, Kristina Lindemann, Péter Fedorcsák, Hanne Stennsheim, Kolawa Wojciech, Kazimierz Pityński, Marta Bałajewicz‐Nowak, Stefan Sajdak, Ewa Kalinka‐Warzocha, E. Lampka, Anna Skrzypczyk-ostaszew, Paula Duarte, Fátima Cardoso, Tudor Buţureanu, Anastasia Porokonnaya, Vladim Bezrukkikh, Elena Ulrikh, Igor Govorov, Alexey Belyaey, Sonsoles Alonso Salvador, Ignacio Zapardiel, Blanca Gil‐Ibáñez, Sonia Baulies, Natalia R. Gómez‐Hidalgo, Ernesto González‐Mesa, Elsa Mendizábal, Kenny A. Rodriguez‐Wallberg, Chahin Achtari, Christine E. Brambs, Ruud L.M. Bekkers, J. de Haan, Christianne J.M. de Groot, Sanne J. Gordijn, Judith R. Kroep, Rebecca C. Painter, C.P. Schröder, Teska Schuurman, Ingeborg J. H. Vriens, Annemarie Thijs, Martine van Grotel, Els O. Witteveen, Annie Armstrong, Santiago Scasso, Alexandra Thomas, Clarissa Bonanno, Jorge Hoegl,
Importance Chemotherapy during the first trimester of pregnancy should be avoided owing to the risk of congenital malformations. However, the precise gestational age at which chemotherapy can be initiated safely remains unclear. Objective To assess congenital malformation rates associated with gestational age at initiation of chemotherapy among pregnant women with cancer. Design, Setting, and Participants This multicenter cohort study evaluated all pregnant women who received chemotherapy between 1977 and ...
Tópico(s): Multiple and Secondary Primary Cancers
2021 - American Medical Association | JAMA Network Open
Barbara Buonomo, Claudia Massarotti, Miriam Dellino, Paola Anserini, Alberta Ferrari, Maria Campanella, Mirosa Magnotti, Cristofaro De Stefano, Fedro A. Peccatori, Matteo Lambertini,
Abstract Background Healthy individuals and patients with cancer who are carriers of germline pathogenic variants in the BRCA1/2 genes face multiple reproductive challenges that require appropriate counseling and specific expertise. Main body On December 5th–7th, 2019, patient advocates and physicians with expertise in the field of reproductive medicine, fertility preservation, and oncology were invited to “San Giuseppe Moscati” Hospital in Avellino (Italy) for a workshop on reproductive management ...
Tópico(s): Prenatal Screening and Diagnostics
2021 - BioMed Central | BMC Medicine
Produção Nacional
Revisado por pares
Matteo Lambertini, Marcello Ceppi, Anne-Sophie Hamy, Olivier Caron, Philip D. Poorvu, Estela Carrasco, Albert Grinshpun, Kevin Punie, Christine Rousset‐Jablonski, Alberta Ferrari, Shani Paluch–Shimon, Angela Toss, Claire Sénéchal, Fabio Puglisi, Katarzyna Pogoda, José Alejandro Pérez Fidalgo, Laura De Marchis, Riccardo Ponzone, Luca Livraghi, Maria Del Pilar Estevez Diz, Cynthia Villarreal‐Garza, Maria Vittoria Dieci, Florian Clatot, François P. Duhoux, Rossella Graffeo, Luís Teixeira, Octavi Córdoba, Amir Sonnenblick, Arlindo R. Ferreira, Ann H. Partridge, Antonio Di Meglio, Claire Saule, Fedro A. Peccatori, M. Bruzzone, Marie Daphne t’Kint de Roodenbeke, Lieveke Ameye, Judith Balmañà, Lucia Del Mastro, Hatem A. Azim,
Abstract Young breast cancer (BC) patients carrying a germline BRCA pathogenic variant ( mBRCA ) have similar outcomes as non-carriers. However, the impact of the type of gene ( BRCA1 vs. BRCA2 ) and hormone receptor status (positive [HR+] vs. negative [HR−]) on clinical behavior and outcomes of mBRCA BC remains largely unknown. This is an international, multicenter, hospital-based, retrospective cohort study that included mBRCA patients diagnosed, between January 2000 and December 2012, with stage I–III invasive ...
Tópico(s): Male Breast Health Studies
2021 - Nature Portfolio | npj Breast Cancer
Giovanna Scarfone, Monica Fumagalli, Martina Imbimbo, Tommaso Ceruti, Fulvia Milena Cribiù, Eugenia Di Loreto, Maurizio D’Incalci, Federica Facchin, Camilla Fontana, Marina Chiara Garassino, Fedro A. Peccatori, Nicola Persico, Diego Signorelli, Massimo Zucchetti,
This is the first case report of a patient with ALK-rearranged metastatic lung adenocarcinoma who became pregnant during treatment with alectinib. A multidisciplinary team of gynecologists, neonatologists, oncologists, psychologists, and pharmacologists was set up to handle the case. According to patient’s preference, the study drug was continued throughout pregnancy and the woman delivered a healthy baby girl at 35 weeks and 5 days of gestation. Fetal parameters remained normal during pregnancy. ...
Tópico(s): Ovarian cancer diagnosis and treatment
2021 - Elsevier BV | Journal of Thoracic Oncology
Barbara Buonomo, Francesco Multinu, Jvan Casarin, Ilaria Betella, Vanna Zanagnolo, Giovanni Aletti, Fedro A. Peccatori,
Ovarian transposition aims to minimize ovarian exposure and damage during pelvic radiotherapy. One or both ovaries are separated from the uterus and mobilized away from the area where the radiation will be administered. A review of the available literature was conducted to evaluate the efficacy and safety of ovarian transposition among pre-menopausal women diagnosed with cervical cancer and eligible for pelvic radiotherapy. Outcomes evaluated were ovarian function preservation and complication rates. ...
Tópico(s): Ovarian cancer diagnosis and treatment
2021 - BMJ | International Journal of Gynecological Cancer
Matteo Lambertini, Fedro A. Peccatori, Isabelle Demeestere, Frédéric Amant, Christine Wyns, Jan‐Bernd Stukenborg, Shani Paluch–Shimon, M Halaška, Cathérine Uzan, Julia Meißner, Michael von Wolff, Richard A. Anderson, Karin Jordan,
•These ESMO Clinical Practice Guidelines provide recommendations for:○Fertility preservation strategies in post-pubertal cancer patients, including those with hereditary cancer syndromes.○The management of post-treatment pregnancies in cancer survivors, including those with hereditary cancer syndromes.•Management flowcharts for fertility preservation strategies are also provided.•Recommendations were compiled by the authors based on available scientific data and the authors' collective expert opinion.
Tópico(s): Ovarian function and disorders
2020 - Elsevier BV | Annals of Oncology